Phenotypeca wins Bioinformatics commercial contract with Tribune Therapeutics

February 2022

Phenotypeca just announced that it has been awarded a consultancy contract with Tribune Therapeutics. Phenotypeca will be working with the Stockholm based biopharmaceutical company to support the expression of one of its proprietary proteins.  The Phenotypeca team has significant expertise in molecular biology, high‑throughput screening, fermentation and large-scale cGMP industrial biopharmaceutical manufacturing.